Olivia Oana Stanciu

Dr. Olivia Oana Stanciu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2025 in Children
Verified
Journal Article
Open access
PDF file
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
MAMircea Andriescu
Mircea Andriescu
AMAndreea Moga
Andreea Moga
CCCaragata Ruxandra Caragata
Caragata Ruxandra Caragata
LBLaura Balanescu
Laura Balanescu
BRBalanescu Radu
Balanescu Radu
Background: Recurrent urinary tract infections (rUTIs) in children are increasingly complicated by antimicrobial resistance, leading to limited treatment options and challenging prophylactic management. Continuous local monitoring of resistance trends is essential for evidence-based stewardship. Methods: This retrospective study analysed recurrent paediatric UTI recorded between 2020 and 2024 at a tertiary hospital in Romania. Data were extracted using the ICD-10 code N39.0 and included demographic, clinical, and microbiological variables. Antimicrobial susceptibility testing followed CLSI standards. Associations between multidrug resistance (MDR) and clinical factors were assessed with χ2 tests and Cramer’s V, and predictors of MDR were evaluated by multivariable logistic regression. Temporal trends in resistance were examined using logistic regression with year as a continuous variable, and results were validated with the non-parametric Cochran–Armitage linear-by-linear χ2 trend test to strengthen analytical rigour. Proportions are presented with Wilson 95% confidence intervals (CIs). Results: A total of 134 children met inclusion criteria for rUTI, of whom 130 had complete demographic and microbiological data and were included in analyses. Each episode represented a distinct culture-confirmed infection occurring ≥30 days apart. MDR occurred in 48.5% of isolates (95% CI, 40.2–56.9) and ESBL in 20.9% (95% CI, 14.9–28.5). MDR was significantly associated with urinary tract malformations (χ2 = 5.78, p = 0.016) and continuous antibiotic prophylaxis (χ2 = 4.23, p = 0.040). Neither logistic nor Cochran–Armitage trend analyses demonstrated a significant temporal increase in MDR (OR per year = 0.94; 95% CI 0.75–1.17; p = 0.566; χ2 = 0.89; p = 0.346). Conclusions: MDR and ESBL rates among children with recurrent UTIs remain high but stable. The combined use of parametric and non-parametric trend analyses confirmed the absence of a significant upward trajectory, underscoring the need for ongoing surveillance and stewardship to maintain antibiotic effectiveness in paediatric care.

22 February 2026 in Children
Verified
Journal Article
Open access
PDF file
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
AMAndreea Moga
Andreea Moga
BRBalanescu Radu
Balanescu Radu
MAMircea Andriescu
Mircea Andriescu
Background: Ipsilateral concomitant ureteropelvic junction (UPJ) and ureterovesical junction (UVJ) obstruction is an uncommon but clinically important pediatric condition. Because standard imaging often detects only one level of obstruction, the coexistence of both lesions is frequently overlooked. Delayed diagnosis may result in persistent hydronephrosis, recurrent urinary tract infections, and progressive renal injury. This systematic review synthesizes current evidence regarding diagnostic challenges, management strategies, and outcomes in children with dual UPJ–UVJ obstruction. Methods: A systematic review following PRISMA 2020 guidelines was conducted and prospectively registered in PROSPERO. Major databases were searched for studies describing pediatric patients with confirmed ipsilateral UPJ + UVJ obstruction. Extracted data included clinical presentation, diagnostic pathways, imaging modalities, timing of diagnosis, surgical sequencing, and postoperative outcomes. Results: Across the 8 included studies, preoperative recognition of dual obstruction was uncommon. Most cases were diagnosed intraoperatively when retrograde stent passage failed or postoperatively when hydronephrosis persisted after an apparently adequate first procedure. Retrograde or antegrade pyelography consistently outperformed ultrasonography and diuretic renography in identifying distal pathology. Staged repair—typically beginning with pyeloplasty—emerged as the most reliable approach, as correction of the proximal obstruction alone frequently improved distal drainage. UVJ-first strategies were less effective and often required secondary pyeloplasty. Endoscopic and minimally invasive techniques showed promise in selected patients but were reported in limited numbers with short follow-up. Functional renal outcomes generally stabilized or improved following complete correction, particularly when intervention occurred early in life. Conclusions: Dual UPJ–UVJ obstruction remains a diagnostic challenge in pediatric urology. Complementing standard imaging with contrast pyelography and maintaining vigilance during intraoperative stent placement can improve detection. Available reports suggest that a staged proximal-first surgical strategy can optimize drainage and reduce the risk of unnecessary distal reconstruction. Early intervention appears beneficial for renal recovery, though long-term outcomes remain insufficiently studied. Ongoing follow-up is essential, particularly in children with recurrent urinary tract infections or persistent hydronephrosis.

12 February 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
MAMircea Andriescu
Mircea Andriescu
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
ISIulia Stoicescu
Iulia Stoicescu
LBLaura Balanescu
Laura Balanescu
RBRadu Balanescu
Radu Balanescu
Introduction: Choosing the appropriate surgical procedure for distal hypospadias is challenging due to the numerous techniques currently used. Urethral mobilization is an adjunctive surgical technique that aims to improve the position of the urethral meatus. We present our experience with a technique of urethral advancement in 70 cases of distal hypospadias. Materials and methods: We retrospectively reviewed the charts of patients with hypospadias for whom pyramid urethral advancement was performed between 2022 and 2025 in our center. Technique description: Dissection and mobilization of the native urethra along with the corpus spongiosum from the penile shaft—the dissection is performed in a pyramidal manner, addressing all planes of the native urethra along with the attached corpus spongiosum after transection of the lateral attachments of the “V-shaped” spongiosum from the base of the glans; mobilization of the urethra and corpus spongiosum “en bloc” along the corpus cavernosum thus exposing the inter-cavernosum groove. Next, a longitudinal, median incision is made in the avascular plane between the two corpus cavernosum in which the urethra-spongiosum complex is inserted and advanced distally. The results were satisfactory with good functional and cosmetic outcome and 4 patients who presented meatal stenosis. Discussion: The technique we propose combines elements from multiple procedures. The main rationale for this approach is to correct the defect using the child's native urethra and avoid a suture urethroplasty with its complications. Pyramid urethral mobilization can also successfully be applied in hypospadias redo cases if inclusion criteria are met. The main amendment in the procedure we performed is the longitudinal, median incision made in the avascular plane between the two corpus cavernosum. Conclusion. Urethral advancement by pyramid repair is a valid option for distal hypospadias and redo cases but precise case selection is mandatory when considering this procedure.

24 October 2025 in Children
Verified
Journal Article
Open access
PDF file
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
AMAndreea Moga
Andreea Moga
LBLaura Balanescu
Laura Balanescu
BRBalanescu Radu
Balanescu Radu
MAMircea Andriescu
Mircea Andriescu
Background: Continuous antibiotic prophylaxis (CAP) is widely used in infants with vesicoureteral reflux (VUR) to prevent recurrent urinary tract infections and renal scarring. However, this practice entails prolonged low-dose antibiotic exposure during a critical period of microbiome establishment, potentially influencing long-term microbial and immune development. Methods: A systematic review was conducted according to PRISMA 2020 guidelines. PubMed, Embase, Scopus, Web of Science, and the Cochrane Library were searched up to September 2025 for studies evaluating gut or urinary microbiome changes in children receiving CAP for VUR. Eligible studies included human participants under 18 years with microbiome outcomes assessed by sequencing or culture-based methods. Results: Twenty-one records were identified, and four studies met inclusion criteria—three observational microbiome studies and one randomized controlled trial. CAP preserved overall microbial alpha diversity but induced compositional changes, notably enrichment of Enterobacteriaceae and reduction in Bifidobacteriaceae. The included RCT confirmed reduced UTI recurrence but increased antimicrobial resistance and non–E. coli infections. Conclusions: CAP in early life maintains microbial diversity but alters microbiota composition and resistance profiles. Identifying these shifts may support individualized prophylaxis strategies and microbiome-preserving interventions to balance infection prevention with ecological safety in infancy.

3 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
MAMircea Andriescu
Mircea Andriescu
AMAndreea Moga
Andreea Moga
CCCaragata Ruxandra Caragata
Caragata Ruxandra Caragata
LBLaura Balanescu
Laura Balanescu
BRBalanescu Radu
Balanescu Radu
Background: Recurrent urinary tract infections (rUTIs) in children are increasingly complicated by antimicrobial resistance, leading to limited treatment options and chal-lenging prophylactic management. Continuous local monitoring of resistance trends is essential for evidence-based stewardship. Methods: This retrospective study analysed 130 episodes of recurrent paediatric UTI recorded between 2020 and 2024 at a tertiary hospital in Romania. Data were extracted using the ICD-10 code N39.0 and included demographic, clinical, and microbiological variables. Antimicrobial susceptibility testing followed CLSI standards. Associations between multidrug resistance (MDR) and clinical factors were assessed with χ² tests and Cramer’s V, and predictors of MDR were evaluated by multivariable logistic regression. Temporal trends in resistance were examined using logistic regression with year as a continuous variable, and results were validated with the non-parametric Cochran–Armitage linear-by-linear χ² trend test to strengthen analytical rigor. Proportions are presented with Wilson 95% confidence intervals (CIs). Results: MDR occurred in 48.5% of isolates (95% CI, 40.2–56.9) and ESBL in 20.9% (95% CI, 14.9–28.5). MDR was significantly associated with urinary tract malformations (χ² = 5.78, p = 0.016) and continuous antibiotic prophylaxis (χ² = 4.23, p = 0.040). Neither logistic nor Cochran–Armitage trend analyses demonstrated a significant temporal increase in MDR (OR per year = 0.94; 95% CI 0.75–1.17; p = 0.566; χ² = 0.89; p = 0.346). Conclusions: MDR and ESBL rates among children with recurrent UTIs remain high but stable. The combined use of parametric and non-parametric trend analyses confirmed the absence of a significant upward trajectory, underscoring the need for ongoing surveillance and stewardship to maintain antibiotic effectiveness in paediatric care.

3 February 2026 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
Olivia Oana StanciuOlivia Oana Stanciu
Olivia Oana Stanciu
AMAndreea Moga
Andreea Moga
LBLaura Balanescu
Laura Balanescu
MAMircea Andriescu
Mircea Andriescu
CCCaragata Ruxandra Caragata
Caragata Ruxandra Caragata
BRBalanescu Radu
Balanescu Radu
Background: Severe lower urinary tract dysfunction (LUTD) in neurologically and anatomically normal children is uncommon and frequently underdiagnosed. When severe, functional voiding disorders may closely mimic obstructive or reflux pathology, leading to diagnostic errors, unnecessary invasive procedures, and potential risk to the upper urinary tract. Case presentation: We present three pediatric cases (aged 3–10 years) referred for recurrent febrile urinary tract infections, incontinence, or acute urinary retention in the absence of neurological or structural abnormalities. Urodynamic evaluation identified three distinct severe functional phenotypes: detrusor overactivity with reduced bladder capacity, poor compliance with detrusor–sphincter dyssynergia and secondary high-grade vesicoureteral reflux (Hinman syndrome), and detrusor underactivity with significant post-void residual volumes. All patients demonstrated marked bladder wall remodeling on cystoscopy, including trabeculation and pseudopolypoid mucosal changes. Case discussion: Despite similar clinical severity, the cases illustrated substantial functional heterogeneity and differing risks of upper urinary tract involvement. Urodynamic phenotyping proved central to diagnosis, differentiation from structural disease, and treatment planning. Multimodal conservative management—including urotherapy, pelvic floor biofeedback, targeted pharmacologic therapy, and, when indicated, clean intermittent catheterization or antibiotic prophylaxis—led to resolution of recurrent infections and meaningful improvement in bladder function during medium-term follow-up, although symptom recurrence occurred in one patient after treatment withdrawal. Conclusions: These cases highlight the heterogeneity and potential reversibility of severe functional LUTD in otherwise healthy children. Early functional recognition based on urodynamic assessment is essential to avoid misdiagnosis, prevent unnecessary surgical intervention, and protect renal function. Conservative, function-oriented management remains the cornerstone of effective treatment. The findings are discussed in the context of the existing literature on severe non-neurogenic LUTD and Hinman syndrome.